The blockade of aberrant hedgehog (Hh) signaling has shown promise for therapeutic intervention in cancer. A cell-based phenotypic highthroughput screen was performed, and the lead structure (1) was identified as an inhibitor of the Hh pathway via antagonism of the Smoothened receptor (Smo). Structure-activity relationship studies led to the discovery of a potent and specific Smoothened antagonist N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4 0 -(trifluoromethoxy)biphenyl-3-carboxamide (5m, NVP-LDE225), which is currently in clinical development.
When in the closed form, the substrate translocation channel of the proteasome core
particle (CP) is blocked by the convergent N termini of α-subunits. To
probe the role of channel gating in mammalian proteasomes, we deleted the N-terminal
tail of α3; the resulting α3ΔN proteasomes are intact
but hyperactive in the hydrolysis of fluorogenic peptide substrates and the
degradation of polyubiquitinated proteins. Cells expressing the hyperactive
proteasomes show markedly elevated degradation of many established proteasome
substrates and resistance to oxidative stress. Multiplexed quantitative proteomics
revealed ∼200 proteins with reduced levels in the mutant cells. Potentially
toxic proteins such as tau exhibit reduced accumulation and aggregate formation.
These data demonstrate that the CP gate is a key negative regulator of proteasome
function in mammals, and that opening the CP gate may be an effective strategy to
increase proteasome activity and reduce levels of toxic proteins in cells.
The 26S proteasome is the primary machinery that degrades ubiquitin (Ub)-conjugated proteins, including many proteotoxic proteins implicated in neurodegeneraton. It has been suggested that the elevation of proteasomal activity is tolerable to cells and may be beneficial to prevent the accumulation of protein aggregates. Here we show that purified proteasomes can be directly transported into cells through mesoporous silica nanoparticle-mediated endocytosis. Proteasomes that are loaded onto nanoparticles through non-covalent interactions between polyhistidine tags and nickel ions fully retain their proteolytic activity. Cells treated with exogenous proteasomes are more efficient in degrading overexpressed human tau than endogenous proteasomal substrates, resulting in decreased levels of tau aggregates. Moreover, exogenous proteasome delivery significantly promotes cell survival against proteotoxic stress caused by tau and reactive oxygen species. These data demonstrate that increasing cellular proteasome activity through the direct delivery of purified proteasomes may be an effective strategy for reducing cellular levels of proteotoxic proteins.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.